Amino acid residues 288 to 302 of the fusion protein of measles virus were predicted by a variety of methods to represent a putative T cell epitope. This sequence was synthesized and the peptide was injected into mice of six inbred strains to test this possibility. Lymphocytes from peptide-immunized mice from all six H-2 disparate strains were able to mount a proliferative response following in vitro culture with the peptide. In addition, lymphocytes from three strains also proliferated in the presence of live measles virus. The peptide also behaved as a B cell epitope in that immunization with free peptide in adjuvant resulted in anti-peptide antibody production in all mouse strains. However, these antibodies did not react with the virus in either a solid-phase immunoassay or a virus neutralization assay. Peripheral blood lymphocytes from 10 laboratory personnel with a prior history of exposure to measles virus were tested in a proliferation assay with the peptide and with the virus. Lymphocytes from all 10 individuals proliferated in response to culture with the virus and those from eight responded to the peptide. These results give further support to the concept of permissive interaction of antigenic peptides with a wide range of class II major histocompatibility complex molecules both in mice and man and indicate the possibility of designing peptides that could be used as components of a synthetic vaccine for use in man.
BastinJ., RothbardJ., DaveyJ., JonesI., TownsendA. R.1987; Use of synthetic peptides of influenza nucleoprotein to define epitopes recognised by class I-restricted cytotoxic T lymphocytes. Journal of Experimental Medicine 165:1508–1523
BhayaniH., PatersonY.1989; Analysis of peptide binding patterns in different MHC/T-cell receptor complexes using pigeon cytochrome-specific T-cell hybridomas. Journal of Experimental Medicine 170:1609–1625
BjorkmanP., SaperM. A., SamraouiB., BennettW. S., StromingerJ. L., WileyD. C.1987; Structure of the human class I histocompatibility antigen HLA-A2. Nature; London: 329506–512
BrownJ. H., JardetzkyT., SapperM. A., SamraouiB., BjorkmanP. J., WileyD. C.1988; A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature; London: 332845–850
BuusS., SetteA., ColonS., MilesC., GreyH. M.1987; The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 235:1353–1358
CeaseK., MargalitH., CornetteJ., PutneyS., RobeyW., OuyangC., StreicherH., FischingerP. J., GalloR. C., DelisiC., BerzofskyJ. A.1987; Helper T cell antigenic site identification in the acquired immunodeficiency syndrome virus gpl20 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proceedings of the National Academy of Sciences, U.S.A 84:4249–4253
CepelliniR., FrumentoG., FerraG. B., TosiR., ChersiA., PernisB.1989; Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature; London: 339392–394
DeLisiC., BerzofskyJ. A.1985; T cell antigenic sites tend to be amphipathic structures. Proceedings of the National Academy of Sciences, U.S.A 82:7048–7053
FriedmanA., ZerubavelR., GitlerC., CohenI. R.1983; Molecular events in the processing of avidin by antigen processing cells (APC). II. Identical processing by APC of H-2 high- and low-responder mouse strains. Immunogenetics 18:277–282
GuilletJ., LaiM., BrinerJ., SmithJ., GefterM.1986; Interaction of peptide antigens and class II major histocompatibility antigens. Nature; London: 324260–262
KaneK. P., VitteloA., ShermanL. A., MesherM. F.1989; Cytolytic T lymphocyte response to isolated class I H-2 proteins and influenza peptides. Nature; London: 340157–159
LambJ. R., IvanyiJ., ReesA. D. M., RothbardJ. B., HowlandK., YoungR. A., YoungD. B.1987; Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO Journal 6:1245–1249
LambJ. R., ReesA. D. M., BalV., IkedaH., WilkinsonD., DevriesR. R. P., RothbardJ. B.1988; Prediction and identification of an HLA-DR restricted T cell determinant in the 19-KD protein of Mycobacterium tuberculosis. European Journal of Immunology 18:973–976
LambJ. R., LathigraR., RothbardJ., SweetserD., YoungR. A., IvanyiJ., YoungD. B.1989; Identification of mycobacterial antigens recognized by T lymphocytes. Reviews of Infectious Diseases 11: supplement 2 S443–450
MerzD. C., ScheidA., ChoppinP. W.1980; The importance of antibody to fusion protein (F) of paramyxoviruses in the prevention of spread of infection. Journal of Experimental Medicine 151:275–288
RichardsonC., HullD., GreerP., HaselK., BerkovichA., EnglandG., BelliniW., RimaB., LazzariniR.1986; The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology 155:508–523
RothbardJ., LechlerR. I., HowlandK., BalV., EckelsD. D., SekalyR., LongE. O., TaylorW. R., LambJ. R.1988; Structural model of HLA-DR restricted T cell antigen recognition. Cell 52:515–523
SetteA., BuusS., ColonS., SmithJ. A., MilesC., GreyH. M.1987; Structural characteristics of an antigen required for its interaction with la and recognition by T cells. Nature; London: 328395–399
SetteA., BuusS., AppellaE., SmithJ. A., ChestnutR., MilesC., ColonS. M., GreyH. M.1989a; Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proceedings of the National Academy of Sciences, U.S.A 86:3296–3300
SetteA., BuusS., ColonS., MilesC., GreyH. M.1989b; Structural analysis of peptides capable of binding to more than one la antigen. Journal of Immunology 142:35–40
SlnigagliaF., GuttingerM., KilgusJ., DoranD. M., MatileH., EtlingerH., TzzeciakA., GillessenO., PinkJ. R. L.1988; A malaria T cell epitope recognised in association with most mouse and human class II molecules. Nature; London: 336778–780
TakahashiH., CohenJ., HosmahnA., CeaseK. B., HoughtenR., CornetteJ. L., DeLisiC., MossB., GermainR. N., BerzofskyJ. A.1988; An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognised by class I MHC restricted murine cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences, U.S.A 85:3105–3109
TownsendA. R., RothbardJ., GotchF. M., BahadurG., WraithD., McmichaelA. J.1986; The epitopes of influenza nucleoprotein recognised by cytotoxic T-lymphocytes can be defined with short synthetic peptides. Cell 44:959–968